Integra LifeSciences to Spotlight CereLink® Intracranial
The Integra LifeSciences' CereLink ICP Monitoring System will be highlighted in booth #655 at AANS Annual Meeting in Chicago, Illinois....
Stay updated with breaking news from Mike Mcbreen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Integra LifeSciences' CereLink ICP Monitoring System will be highlighted in booth #655 at AANS Annual Meeting in Chicago, Illinois....
Integra LifeSciences (Nasdaq: IART) completed its previously announced acquisition of Acclarent from Johnson & Johnson MedTech.
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology...
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of
Acclarent, an Irvine-based maker of minimally invasive technologies for the ears, nose and throat sector, is being sold by parent Johnson & Johnson for $275 million to Integra LifeSciences Holdings Corp.